Unlocking the Future of Health: Strategic Overview of Cell and Gene Therapy Content

icon_featured_hand

October 01, 2024

Over the past decade, the number of cell and gene therapies (CGTs) and the scope of diseases they treat have undergone significant transformation. By the end of 2023, there were 76 CGTs available worldwide, double the number of therapies launched 10 years earlier.1

The rich clinical pipeline, fueling the projected number of therapies poised to enter the market in the next decade, will be transformational for care delivery and disease treatment, but also increasingly unaffordable for payers globally. Employers and public payers alike are considering how to fund and create access to these multimillion-dollar treatments for a growing number of patients who need them.

To help navigate this complex topic, Business Group on Health has curated a list of resources that provides much-needed information about developing effective, affordable and equitable CGT benefit strategies.

Unlock DNA

Business Group Cell and Gene Therapy Related Resources

Icon Discover Discover What CGT Is All About

  • Hear from Sarah Emond, President and CEO at the Institute for Clinical & Economic Review (ICER), on the Business Group podcast episode 'Cell and Gene Therapy: Tapping into the Potential of Curative Treatment.' In this episode, she discusses the advantages these new therapies can offer patients, challenges in administration and financing, as well as various pricing models for these treatments.

Icon Review Review Considerations in CGT Strategy

Icon Learn Learn from CGT Experts

  • Check out the webinar recap, Genetics in Medicine, which highlights key themes from the Genetics Innovation Showcase.

Connect and Engage with the Business Group

Get involved in the Business Group. Take full advantage of your membership

Participate in Institutes and Committees

Engage with the Employer Community

Have a question about CGT? Share your questions or subject matter expertise with fellow employer members in the online forum.

GO

Share Your Experience


If you have an innovative CGT strategy or solution, the Business Group would love to learn more and highlight your work to fellow members.

GO


References

  • 1 | IQVIA. Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. March 3, 2024. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed July 18, 2024 .

More Topics

Resource icon_right_chevron_dark Cost Management icon_right_chevron_dark Value-Based Care icon_right_chevron_dark Vendor Management icon_right_chevron_dark
More in Benefits Strategy